A record surge in Moderna Inc.’s shares delivered a $5.5 billion blow to short sellers who had bet that the vaccine maker’s years-long slump would continue.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.